It's a pointless argument sevo.
What's important is will they make sufficient amount of money from it. Does the share price reflect those cash flows. Are we overvalued or seriously undervalued.
Internal rates of return are 33% here for the project as a whole.
NPV is $500m.
MC is <$30m.
- Forums
- ASX - By Stock
- APC
- Ann: Exceptionally Strong Scoping Study Findings
Ann: Exceptionally Strong Scoping Study Findings, page-60
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.070M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
APC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online